WO2002083868A3 - Peroxide-driven cytochrome p450 oxygenase variants - Google Patents
Peroxide-driven cytochrome p450 oxygenase variants Download PDFInfo
- Publication number
- WO2002083868A3 WO2002083868A3 PCT/US2002/011954 US0211954W WO02083868A3 WO 2002083868 A3 WO2002083868 A3 WO 2002083868A3 US 0211954 W US0211954 W US 0211954W WO 02083868 A3 WO02083868 A3 WO 02083868A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cytochrome
- variants
- peroxide
- driven
- compared
- Prior art date
Links
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 title abstract 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 title abstract 2
- 150000002978 peroxides Chemical class 0.000 title abstract 2
- 101000745610 Bacillus megaterium (strain ATCC 14581 / DSM 32 / JCM 2506 / NBRC 15308 / NCIMB 9376 / NCTC 10342 / NRRL B-14308 / VKM B-512) NADPH-cytochrome P450 reductase Proteins 0.000 abstract 2
- 102220498987 Phosphatidylinositol 4-phosphate 5-kinase type-1 beta_F87A_mutation Human genes 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 102200105384 rs387906979 Human genes 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/14—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen (1.14.14)
- C12Y114/14001—Unspecific monooxygenase (1.14.14.1)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002307340A AU2002307340A1 (en) | 2001-04-16 | 2002-04-16 | Peroxide-driven cytochrome p450 oxygenase variants |
EP02762117A EP1470219A4 (en) | 2001-04-16 | 2002-04-16 | Peroxide-driven cytochrome p450 oxygenase variants |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28421501P | 2001-04-16 | 2001-04-16 | |
US60/284,215 | 2001-04-16 | ||
US28863601P | 2001-05-03 | 2001-05-03 | |
US60/288,636 | 2001-05-03 | ||
US34060201P | 2001-12-12 | 2001-12-12 | |
US60/340,602 | 2001-12-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002083868A2 WO2002083868A2 (en) | 2002-10-24 |
WO2002083868A3 true WO2002083868A3 (en) | 2004-08-05 |
Family
ID=27403454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/011954 WO2002083868A2 (en) | 2001-04-16 | 2002-04-16 | Peroxide-driven cytochrome p450 oxygenase variants |
Country Status (4)
Country | Link |
---|---|
US (2) | US7465567B2 (en) |
EP (1) | EP1470219A4 (en) |
AU (1) | AU2002307340A1 (en) |
WO (1) | WO2002083868A2 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083868A2 (en) | 2001-04-16 | 2002-10-24 | California Institute Of Technology | Peroxide-driven cytochrome p450 oxygenase variants |
US7226768B2 (en) | 2001-07-20 | 2007-06-05 | The California Institute Of Technology | Cytochrome P450 oxygenases |
EP1639091B1 (en) * | 2003-06-17 | 2012-12-05 | California University Of Technology | Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
WO2005017116A2 (en) * | 2003-08-11 | 2005-02-24 | California Institute Of Technology | Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
US11214817B2 (en) | 2005-03-28 | 2022-01-04 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
US8715988B2 (en) * | 2005-03-28 | 2014-05-06 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
US8026085B2 (en) * | 2006-08-04 | 2011-09-27 | California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
US8252559B2 (en) * | 2006-08-04 | 2012-08-28 | The California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
WO2008121435A2 (en) * | 2007-02-02 | 2008-10-09 | The California Institute Of Technology | Methods for generating novel stabilized proteins |
US20080268517A1 (en) * | 2007-02-08 | 2008-10-30 | The California Institute Of Technology | Stable, functional chimeric cytochrome p450 holoenzymes |
US8802401B2 (en) | 2007-06-18 | 2014-08-12 | The California Institute Of Technology | Methods and compositions for preparation of selectively protected carbohydrates |
GB0719620D0 (en) * | 2007-10-08 | 2007-11-14 | Isis Innovation | Mutant Enzymes |
EP2426198A1 (en) | 2010-09-03 | 2012-03-07 | B.R.A.I.N. Biotechnology Research And Information Network AG | Cytochrome P450 monooxygenase variants |
WO2013016207A2 (en) | 2011-07-22 | 2013-01-31 | California Institute Of Technology | Stable fungal cel6 enzyme variants |
WO2015048572A1 (en) | 2013-09-27 | 2015-04-02 | Codexis, Inc. | Automated screening of enzyme variants |
JP6945937B2 (en) | 2016-05-09 | 2021-10-13 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Detergent composition containing fatty acid converting enzyme |
EP3556835A1 (en) * | 2016-05-09 | 2019-10-23 | The Procter & Gamble Company | Detergent composition comprising a fatty acid decarboxylase |
ES2721224T3 (en) | 2016-05-09 | 2019-07-29 | Procter & Gamble | Detergent composition comprising an oleic acid transforming enzyme |
EP3798293A1 (en) | 2019-09-27 | 2021-03-31 | The Procter & Gamble Company | Detergent composition |
EP3798292A1 (en) | 2019-09-27 | 2021-03-31 | The Procter & Gamble Company | Detergent composition |
EP3798294A1 (en) | 2019-09-27 | 2021-03-31 | The Procter & Gamble Company | Detergent composition |
EP3816271A1 (en) | 2019-10-31 | 2021-05-05 | The Procter & Gamble Company | Detergent composition |
CN112359027B (en) * | 2021-01-13 | 2021-04-13 | 凯莱英生命科学技术(天津)有限公司 | Cytochrome P450 enzyme mutant and application thereof |
WO2023122251A2 (en) * | 2021-12-23 | 2023-06-29 | Manus Bio Inc. | Enzymes, cells, and methods for producing lactones |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4599342A (en) | 1984-01-16 | 1986-07-08 | The Procter & Gamble Company | Pharmaceutical products providing enhanced analgesia |
US5785989A (en) | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
GB8723662D0 (en) | 1987-10-08 | 1987-11-11 | British Bio Technology | Synthetic gene |
JPH0767394B2 (en) | 1991-03-20 | 1995-07-26 | 三洋化成工業株式会社 | Chemiluminescence enhancer, chemiluminescence-based detection / quantification method and kit |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
SK55598A3 (en) | 1995-11-01 | 1999-04-13 | British Gas Plc | Mutant mono-oxygenase cytochrome p450cam |
US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
US5741691A (en) | 1996-01-23 | 1998-04-21 | California Institute Of Technology | Para-nitrobenzyl esterases with enhanced activity in aqueous and nonaqueous media |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
IL130635A0 (en) | 1997-01-17 | 2000-06-01 | Maxygen Inc | Evolution of whole cells and organisms by recursive sequence recombination |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
PL335860A1 (en) | 1997-03-18 | 2000-05-22 | Novo Nordisk As | Method of in vitro constructing a dna library |
US6361988B1 (en) | 1997-03-25 | 2002-03-26 | California Institute Of Technology | ECB deacylase mutants |
US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
CA2313380C (en) | 1997-12-08 | 2008-12-30 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
US5945325A (en) | 1998-04-20 | 1999-08-31 | California Institute Of Technology | Thermally stable para-nitrobenzyl esterases |
US20030077795A1 (en) | 1999-03-10 | 2003-04-24 | Wilson C. Ron | Cytochrome P450 monooxygenase and NADPH Cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicals and methods relating thereto |
US6902918B1 (en) | 1998-05-21 | 2005-06-07 | California Institute Of Technology | Oxygenase enzymes and screening method |
WO2000000632A1 (en) | 1998-06-29 | 2000-01-06 | Phylos, Inc. | Methods for generating highly diverse libraries |
WO2000006718A2 (en) | 1998-07-28 | 2000-02-10 | California Institute Of Technology | Expression of functional eukaryotic proteins |
JP2002522750A (en) | 1998-08-05 | 2002-07-23 | ユニバーシティ・オブ・ピッツバーグ | Modeling the reactivity of organic compounds in cytochrome P450-mediated reactions |
FR2782323B1 (en) | 1998-08-12 | 2002-01-11 | Proteus | PROCESS FOR THE IN VITRO PRODUCTION OF RECOMBINANT POLYNUCLEOTIDE SEQUENCES, SEQUENCE BANKS AND SEQUENCES THUS OBTAINED |
AU1199000A (en) | 1998-09-29 | 2000-04-17 | Maxygen, Inc. | Shuffling of codon altered genes |
GB9825421D0 (en) | 1998-11-19 | 1999-01-13 | Isis Innovation | Process for oxidising terpenes |
US6090604A (en) | 1999-02-24 | 2000-07-18 | Novo Nordisk Biotech, Inc. | Polypeptides having galactose oxidase activity and nucleic acids encoding same |
US6524837B1 (en) | 1999-03-29 | 2003-02-25 | California Institute Of Technology | Hydantoinase variants with improved properties and their use for the production of amino acids |
GB9914373D0 (en) * | 1999-06-18 | 1999-08-18 | Isis Innovation | Process for oxidising aromatic compounds |
US6787343B2 (en) | 1999-11-12 | 2004-09-07 | Washington State University Research Foundation | Cytochrome P450 oxygenases and their uses |
US6498026B2 (en) | 2000-02-25 | 2002-12-24 | Hercules Incorporated | Variant galactose oxidase, nucleic acid encoding same, and methods of using same |
US7115403B1 (en) * | 2000-05-16 | 2006-10-03 | The California Institute Of Technology | Directed evolution of galactose oxidase enzymes |
EP1283877A2 (en) * | 2000-05-23 | 2003-02-19 | California Institute Of Technology | Gene recombination and hybrid protein development |
WO2002083868A2 (en) | 2001-04-16 | 2002-10-24 | California Institute Of Technology | Peroxide-driven cytochrome p450 oxygenase variants |
US7226768B2 (en) | 2001-07-20 | 2007-06-05 | The California Institute Of Technology | Cytochrome P450 oxygenases |
US6906930B2 (en) | 2003-06-26 | 2005-06-14 | Delta Electronics, Inc. | Structure and method for an isolated boost converter |
WO2005017116A2 (en) | 2003-08-11 | 2005-02-24 | California Institute Of Technology | Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
US6873078B1 (en) * | 2003-10-10 | 2005-03-29 | General Atomics | Homopolar machine with improved brush lifetime |
-
2002
- 2002-04-16 WO PCT/US2002/011954 patent/WO2002083868A2/en not_active Application Discontinuation
- 2002-04-16 AU AU2002307340A patent/AU2002307340A1/en not_active Abandoned
- 2002-04-16 EP EP02762117A patent/EP1470219A4/en not_active Withdrawn
- 2002-04-16 US US10/125,640 patent/US7465567B2/en not_active Expired - Lifetime
-
2008
- 2008-10-11 US US12/287,681 patent/US7704715B2/en active Active
Non-Patent Citations (9)
Title |
---|
BIOCHEM. BIOPHYS. RES. COMMUN., vol. 280, no. 5, 9 February 2001 (2001-02-09), pages 1258 - 1261 * |
BIOCHEMISTRY, vol. 34, no. 35, 5 September 1995 (1995-09-05), pages 11221 - 11226 * |
BIOCHEMISTRY, vol. 34, no. 45, 14 November 1995 (1995-11-14), pages 14733 - 14740 * |
DATABASE MEDLINE [online] GOVINDARAJ S. ET AL.: "Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3", XP002976908, accession no. NCBI Database accession no. 7669780 * |
DATABASE MEDLINE [online] LI Q.S. ET AL.: "Critical role of the residue size at position 87 in H2O2-dependent substrate hydroxylation activity and H2O2 inactivation of cytochrome P450BM-3", XP002976907, accession no. NCBI Database accession no. 11162663 * |
DATABASE MEDLINE [online] OST T.W. ET AL.: "Rational re-design of the substrate binding site of flavocytochrome P450 BM3", XP002976905, accession no. NCBI Database accession no. 11113461 * |
DATABASE MEDLINE [online] YEOM H. ET AL.: "The role of Thr268 in oxygen activation of cytochrome P450MB-3", XP002976906, accession no. NCBI Database accession no. 7578081 * |
FEBS LETTERS, vol. 486, no. 2, 8 December 2000 (2000-12-08), pages 173 - 177 * |
NOBLE M.A. ET AL.: "Roles of key active-site residues in flavocytochrome P450 BM3", BIOCHEM. J., vol. 339, 1999, pages 371 - 379, XP001011145 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002307340A1 (en) | 2002-10-28 |
US20050202419A1 (en) | 2005-09-15 |
EP1470219A4 (en) | 2005-10-05 |
EP1470219A2 (en) | 2004-10-27 |
US7465567B2 (en) | 2008-12-16 |
WO2002083868A2 (en) | 2002-10-24 |
US20090142821A1 (en) | 2009-06-04 |
US7704715B2 (en) | 2010-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002083868A3 (en) | Peroxide-driven cytochrome p450 oxygenase variants | |
WO2005017116A3 (en) | Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use | |
WO2002000852A3 (en) | Lipolytic enzyme | |
WO2000047720A3 (en) | Pancreatic progenitor cells, methods and uses related thereto | |
AU2002254876A1 (en) | Alpha-amylase variant with altered properties | |
AU2173899A (en) | Hydroxylation activated prodrugs | |
WO2001027118A3 (en) | Bicyclic imidazo-5-yl-amine derivatives | |
SG161247A1 (en) | Variant forms of urate oxidase and use thereof | |
EP1416050A4 (en) | Method of modifying enzyme and oxidoreductase variant | |
AU2001241674A1 (en) | Variant galactose oxidase, nucleic acid encoding same, and methods of using same | |
ZA200403086B (en) | Drugs comprising combination of triazaspiro[5,5]undecane derivative with cytochrome P450 isozyme 3A4 inhibitor and/or P-glycoprotein inhibitor. | |
GB9509321D0 (en) | Methods of and substances for inhibiting oxidative enzymes | |
AU2002351394A1 (en) | Methods for planarization of group viii metal-containing surfaces using oxidizing gases | |
AU2001265299A1 (en) | Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods | |
WO2000050631A3 (en) | Compositions and methods for monitoring the modification of natural binding partners | |
WO2002033057A3 (en) | Cytochrome p450 monooxygenases consisting of thermophilic bacteria | |
AU2002220697A1 (en) | Isolated luciferases lu164, lual and lu22, and the use of the same | |
CA2238014A1 (en) | Inhibitory and non-inhibitory antigen binding polypeptides against human p450 enzymes | |
AU2531599A (en) | Hydroxylation activated drug release | |
WO2000058352A3 (en) | Barley gene for thioredoxin and nadp-thioredoxin reductase | |
WO2001057236A3 (en) | Process for detecting modulation of nad(p)h oxidoreductase | |
WO2004013283A3 (en) | Thioredoxin mutants and uses thereof | |
WO2003018788A3 (en) | Improved nitroreductase enzymes | |
AU2003257986A1 (en) | Methods and compositions for nad(p)(h) oxidases | |
WO2002103032A3 (en) | Catalases, nucleic acids encoding them and methods for making and using them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002762117 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002762117 Country of ref document: EP |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002762117 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |